Abedalrahman Almashayekh

Researcher

Last publication 2025 Last refreshed 2026-05-16

unknown

1 h-index 4 pubs 1 cited

Biography and Research Information

OverviewAI-generated summary

Abedalrahman Almashayekh's research focuses on various aspects of patient care and treatment outcomes, particularly within the context of complex medical interventions. His recent publications investigate acute kidney injury in patients receiving chimeric antigen receptor (CAR) T cells, examining risk factors and characteristics. Almashayekh also studies hypophosphatemia as a potential marker for immune effector cell-associated neurotoxicity syndrome in CAR T cell recipients. Further research addresses post-transplant lymphoproliferative disorder, highlighting diagnostic challenges after negative needle biopsies. Additionally, his work includes a multicenter case series exploring SGLT2 inhibitors as a therapeutic option for refractory hypomagnesemia in both diabetic and nondiabetic patients. Almashayekh has 4 total publications, with his most recent published in 2025.

Metrics

  • h-index: 1
  • Publications: 4
  • Citations: 1

Selected Publications

  • AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
  • Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)
  • Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)
  • SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series (2025)

View all publications on OpenAlex →

Collaboration Network

19 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics